Our Pipeline
LADRTM Mechanism: Proof of Concept
| Albumin binding | Cleavable linker | Water-solubilizing properties | Release Kinetics | Payload |
||
|---|---|---|---|---|---|---|
| Next Generation Albumin Binding Drug Candidates | LADR-7 LADR-8 LADR-9 LADR-10 | Yes | Yes | Yes | Medium | Auristatin E, Maytansine |
| Proof of Concept | Aldoxorubicin* | Yes | Yes | No | Fast | Doxorubicin |
* licensed to NantCell, Inc.